CAMP4 Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . CAMP4 THERAPEUTICS PORATION
CAMP Stock  USD 3.85  0.54  12.30%   
Analyzing historical trends in various income statement and balance sheet accounts from CAMP4 THERAPEUTICS's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting CAMP4 THERAPEUTICS's valuation are summarized below:
Gross Profit
-36 M
Market Capitalization
200.2 M
Enterprise Value Revenue
34.4117
Revenue
3.8 M
Earnings Share
(10.85)
There are currently one hundred twenty fundamental signals for CAMP4 THERAPEUTICS PORATION that can be evaluated and compared over time across rivals. Investors and active traders are advised to validate CAMP4 THERAPEUTICS's prevailing fundamental performance against the performance between 2010 and 2026 to make sure the trends are evolving in the right direction. As of 02/15/2026, Market Cap is likely to grow to about 130.3 M, while Enterprise Value is likely to drop slightly above 39.7 M.

CAMP4 THERAPEUTICS Total Revenue

712,310

Check CAMP4 THERAPEUTICS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CAMP4 THERAPEUTICS's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 M, Total Revenue of 712.3 K or Gross Profit of 712.3 K, as well as many indicators such as Price To Sales Ratio of 148, Dividend Yield of 0.0 or PTB Ratio of 1.76. CAMP4 financial statements analysis is a perfect complement when working with CAMP4 THERAPEUTICS Valuation or Volatility modules.
  
Build AI portfolio with CAMP4 Stock
Check out the analysis of CAMP4 THERAPEUTICS Correlation against competitors.

CAMP4 THERAPEUTICS Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets152.8 M90.1 M251.9 M
Very volatile
Short and Long Term Debt Total9.4 M9.9 M84.6 M
Very volatile
Total Current Liabilities10.5 M11 M48.6 M
Very volatile
Property Plant And Equipment Net12.6 M11.8 M21.2 M
Slightly volatile
Cash40.4 M73.6 M78.5 M
Pretty Stable
Non Current Assets Total13 M13.7 M98.4 M
Very volatile
Non Currrent Assets Other3.3 M1.9 M5.1 M
Very volatile
Cash And Short Term Investments44.7 M73.6 M87.9 M
Very volatile
Net Receivables118 K124.2 K34.5 M
Pretty Stable
Common Stock Shares Outstanding22.6 M22.4 M29.3 M
Pretty Stable
Liabilities And Stockholders Equity152.8 M90.1 M251.9 M
Very volatile
Non Current Liabilities Total6.1 M6.4 M110.7 M
Pretty Stable
Inventory15.4 M27.5 M22.1 M
Slightly volatile
Other Current Assets2.4 M2.6 M8.8 M
Very volatile
Other Stockholder Equity331.9 M316.1 M195.6 M
Slightly volatile
Total Liabilities16.6 M17.4 M159.2 M
Pretty Stable
Total Current Assets89.9 M76.3 M150.5 M
Very volatile
Short Term Debt6.4 M3.5 M10.1 M
Very volatile
Accounts Payable1.3 M1.4 M17.7 M
Pretty Stable
Common Stock2.2 K2.3 K231.3 K
Slightly volatile
Good Will58 M108.3 M60.2 M
Slightly volatile
Intangible Assets31.7 M30.6 M29.8 M
Slightly volatile
Current Deferred Revenue420.6 K442.8 K13.6 M
Very volatile
Short Term Investments28.4 M20.1 M19.7 M
Pretty Stable
Capital Lease Obligations8.7 M7.8 M11.6 M
Slightly volatile
Property Plant And Equipment Gross14.4 M14.9 M18.9 M
Slightly volatile
Capital Stock1.5 K2.3 K1.2 K
Slightly volatile
Net Working Capital44.1 M51.1 M69.3 M
Slightly volatile

CAMP4 THERAPEUTICS Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.9 M2 M10.9 M
Very volatile
Total Revenue712.3 K749.8 K202.9 M
Slightly volatile
Other Operating Expenses58.7 M61.8 M196 M
Pretty Stable
Cost Of Revenue107.4 M137.1 M154.3 M
Pretty Stable
Total Operating Expenses49.6 M61.8 M80.4 M
Pretty Stable
Research Development46.9 M44.6 M26.7 M
Slightly volatile
Interest Expense7.7 M5.4 M7.5 M
Slightly volatile
Selling General Administrative28.8 M17.2 M27.7 M
Pretty Stable
Selling And Marketing Expenses34.2 M34 M33.8 M
Slightly volatile
Net Interest Income1.8 M1.5 M1.1 M
Slightly volatile
Interest Income1.8 M1.5 M1.1 M
Slightly volatile
Reconciled Depreciation1.6 M2 M1.1 M
Slightly volatile

CAMP4 THERAPEUTICS Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow41.1 M46 M70 M
Pretty Stable
Depreciation1.9 M2 M9.7 M
Very volatile
Capital Expenditures481.8 K507.1 K5.6 M
Very volatile
End Period Cash Flow45.5 M75.5 M80.1 M
Pretty Stable

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio14814170.8513
Slightly volatile
Days Sales Outstanding51.0854.41110
Slightly volatile
Stock Based Compensation To Revenue5.845.572.0287
Slightly volatile
Capex To Depreciation0.280.30.789
Very volatile
EV To Sales67.2964.0847.7223
Slightly volatile
Inventory Turnover5.45.457.0702
Slightly volatile
Days Of Inventory On Hand69.469.2956.0223
Slightly volatile
Payables Turnover9.749.017.8708
Slightly volatile
Sales General And Administrative To Revenue21.6320.67.8183
Slightly volatile
Research And Ddevelopement To Revenue56.2653.5823.6735
Slightly volatile
Capex To Revenue0.640.610.3613
Slightly volatile
Cash Per Share3.12.952.6699
Slightly volatile
Days Payables Outstanding37.841.9550.5058
Pretty Stable
Intangibles To Total Assets0.180.280.2486
Slightly volatile
Current Ratio6.546.224.0541
Slightly volatile
Receivables Turnover8.026.945.5521
Slightly volatile
Capex Per Share0.01930.02030.1711
Pretty Stable
Revenue Per Share0.02860.03015.6589
Slightly volatile
Interest Debt Per Share0.380.42.6304
Pretty Stable
Debt To Assets0.160.09940.2252
Slightly volatile
Graham Number3.756.646.684
Pretty Stable
Operating Cycle98.8854.41150
Slightly volatile
Days Of Payables Outstanding37.841.9550.5058
Pretty Stable
Long Term Debt To Capitalization0.560.530.4114
Slightly volatile
Quick Ratio6.546.223.7213
Slightly volatile
Net Income Per E B T0.711.221.0752
Very volatile
Cash Ratio6.316.02.8348
Slightly volatile
Cash Conversion Cycle66.954.41110
Slightly volatile
Days Of Inventory Outstanding69.469.2956.0223
Slightly volatile
Days Of Sales Outstanding51.0854.41110
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.950.911.0869
Pretty Stable
Fixed Asset Turnover0.05410.05717.8593
Slightly volatile
Debt Ratio0.160.09940.2252
Slightly volatile
Price Sales Ratio14814170.8513
Slightly volatile
Asset Turnover0.00910.00960.7875
Slightly volatile
Gross Profit Margin0.250.350.3679
Pretty Stable

CAMP4 THERAPEUTICS Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap130.3 M91.6 M264.7 M
Slightly volatile
Enterprise Value39.7 M41.8 M318.5 M
Slightly volatile

CAMP4 Fundamental Market Drivers

CAMP4 Upcoming Events

25th of April 2024
Upcoming Quarterly Report
View
8th of July 2024
Next Financial Report
View
29th of February 2024
Next Fiscal Quarter End
View
25th of April 2024
Next Fiscal Year End
View
30th of November 2023
Last Quarter Report
View
28th of February 2023
Last Financial Announcement
View

About CAMP4 THERAPEUTICS Financial Statements

CAMP4 THERAPEUTICS shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although CAMP4 THERAPEUTICS investors may analyze each financial statement separately, they are all interrelated. The changes in CAMP4 THERAPEUTICS's assets and liabilities, for example, are also reflected in the revenues and expenses on on CAMP4 THERAPEUTICS's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue442.8 K420.6 K
Total Revenue749.8 K712.3 K
Cost Of Revenue137.1 M107.4 M
Stock Based Compensation To Revenue 5.57  5.84 
Sales General And Administrative To Revenue 20.60  21.63 
Research And Ddevelopement To Revenue 53.58  56.26 
Capex To Revenue 0.61  0.64 
Revenue Per Share 0.03  0.03 
Ebit Per Revenue(93.64)(88.95)

Pair Trading with CAMP4 THERAPEUTICS

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CAMP4 THERAPEUTICS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CAMP4 THERAPEUTICS will appreciate offsetting losses from the drop in the long position's value.

Moving against CAMP4 Stock

  0.71AVH Avita MedicalPairCorr
  0.71ABNX Abionyx Pharma SAPairCorr
  0.69OB3 OPTIBIOTIX HLTH PLCPairCorr
  0.63JUMP Leveljump Healthcare CorpPairCorr
  0.62CMB Cambium BioPairCorr
The ability to find closely correlated positions to CAMP4 THERAPEUTICS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CAMP4 THERAPEUTICS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CAMP4 THERAPEUTICS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CAMP4 THERAPEUTICS PORATION to buy it.
The correlation of CAMP4 THERAPEUTICS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CAMP4 THERAPEUTICS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CAMP4 THERAPEUTICS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CAMP4 THERAPEUTICS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for CAMP4 Stock Analysis

When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY